相关实验视频
Updated: Sep 15, 2025
16:15
Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
20.9K
2个预后模型的验证,以预测IgA脏病复发后的脏异位移植结果
Emilio Rodrigo1, Luis F Quintana2, Teresa Vázquez-Sánchez3
1Nephrology Department, Hospital Universitario Marqués de Valdecilla/IDIVAL, Universidad de Cantabria, Santander, Spain.
Kidney international reports
|July 18, 2025
概括
移植后IgA脏病的复发是常见的. 国际Igan预测工具 (IIgAN-PT) 和贝德纳罗瓦的预测工具.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植免疫学 移植免疫学
- 预测分析是一种预测分析.
背景情况:
- 移植 (KTx) 后IgA病复发 (IgANr) 是移植损失的重要原因之一.
- 现有的预测工具,如国际Igan预测工具 (IIgAN-PT) 和Bednarova的预测工具 (Bednarova-PT),是为本地或不同人群开发的.
- 这些工具在具有IgANr的KTx群体中的性能需要验证.
研究的目的:
- 评估IIgAN-PT和Bednarova-PT在预测IgA脏病复发的脏移植受体中死亡审查的移植损失 (DCGL) 的表现.
- 在一个不同的队列中评估这些预测模型的准确性和校准.
主要方法:
- 一项多中心的回顾性研究包括120名脏移植接受者,他们的活检证明了IgANr.
- 使用IIgAN-PT和Bednarova-PT来计算DCGL的风险.
- 模型的性能被评估使用歧视 (时间依赖的ROC AUC) 和校准指标,以及卡普兰-梅尔生存分析.
主要成果:
- 两种IIgAN-PT (AUC: 87.3%) 和Bednarova-PT (AUC: 83.5%) 均表现出良好的区分能力来预测DCGL.
- IIgAN-PT显示了更高的校准斜率 (2.49),但倾向于低估高风险个体的风险.
- 卡普兰-梅尔分析显示,通过结合两种工具确定的最高风险组的结果明显分离.
结论:
- IIgAN-PT和Bednarova-PT是有效的工具,用于预测患有IgANr.的移植接受者的DCGL.
- 这些模型具有良好的区分能力和可接受的校准,有助于识别高风险患者.
- 使用这两种预测工具可能会提高移植后IgANr患者的风险分层.
相关概念视频
01:16Kidney Transplant III: Nursing Management
83
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
83
01:29Acute Kidney Injury III: Clinical Manifestations
95
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
95
01:26Kidney Transplant II: Surgical Procedure
77
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
77
01:28Kidney Transplant I: Introduction
60
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
60
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
58
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
58